Viruses are associated with 15-20% of human cancers worldwide. In the last century, many studies were directed towards elucidating the molecular mechanisms and genetic alterations by which viruses cause cancer. The importance of epigenetics in the regulation of gene expression has prompted the investigation of virus and host interactions not only at the genetic level but also at the epigenetic level. In this study, we summarize the published epigenetic information relating to the genomes of viruses directly or indirectly associated with the establishment of tumorigenic processes. We also review aspects such as viral replication and latency associated with epigenetic changes and summarize what is known about epigenetic alterations in host genomes and the implications of these for the tumoral process. The advances made in characterizing epigenetic features in cancer-causing viruses have improved our understanding of their functional mechanisms. Knowledge of the epigenetic changes that occur in the genome of these viruses should provide us with markers for following cancer progression, as well as new tools for cancer therapy.
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Epigenetics
Since 1987, when Robin Holliday defined epigenetics as heritable changes in gene expression that are not due to any alteration in the DNA sequence (Holliday, 1987) , much has been discovered in this field. We now know that epigenetics, which includes the methylation status of DNA and the posttranslational modifications of histones, has an important function in tumorigenesis in mammals (Jones and Baylin, 2002; Esteller, 2008) . The best-known epigenetic marker is DNA methylation, and together with specific histone modifications and specific miRNA signatures, it defines a molecular landscape that is altered in cancer (Fraga and Esteller, 2005; Chuang and Jones, 2007; Lujambio et al., 2007) .
DNA methylation mainly occurs on cytosines that precede guanines to yield 5-methylcytosine; these dinucleotide sites are usually referred to as CpGs (Herman and Baylin, 2003) . CpGs are asymmetrically distributed into CpG-poor regions and dense regions called 'CpG islands', which are located in the promoter regions of approximately half of all genes. These CpG islands are usually unmethylated in normal cells, with the exceptions listed below, whereas the sporadic CpG sites in the rest of the genome are generally methylated (Jones and Takai, 2001) .
DNA methylation is a normal cellular process in mammalian cells that enables the normal expression pattern to be maintained; it is involved in genomic imprinting (Feinberg et al., 2002) , X-chromosome inactivation in females (Payer and Lee, 2008) and silencing parasitic and foreign elements (Doerfler, 1991) , among other processes. However, methylation of CpG islands in promoter regions is often associated with gene silencing, and aberrant DNA methylation occurs in most cancers, leading to the silencing of some tumor-suppressor genes (Jones and Baylin, 2002; Esteller, 2008) .
Viruses and cancer
Since 1898, when Martinus Beijerinck discovered the first known virus, the tobacco mosaic virus, 45000 types of viruses have been described in detail (Breitbart and Rohwer, 2005) . Peyton Rous discovered the first known tumorigenic virus in birds in 1911 and, more recently, in 1964, Michael Anthony Epstein and Yvonne Barr first discovered a virus known to be involved in human cancer (the Epstein-Barr virus, EBV). We now know that viruses infect all types of cells and cause a variety of human diseases, from the common cold to AIDS and cancer.
Viruses produce disease by different routes, depending on the viral species and the specific organ or organism they affect. Viral infection can lead to asymptomatic effects, acute clinical disease, neurological disorders and induction of various cancer types. The interactions between a virus and its host can produce different consequences, from no apparent change in the infected cell to the death of the host cell arising from alterations of the cell membrane and apoptosis (Roulston et al., 1999) . Some viruses can persist over time, despite active immunity, and cause no apparent changes to the infected cell. This latency is a characteristic of the herpes virus group, some members of which, such as the herpes simplex virus, can induce cell proliferation without causing malignancy (Barozzi et al., 2007) , or of the human papilloma virus (HPV) group, several members of which can unleash cancer (zur Hausen, 2009 ).
The proportion of cancers caused by infectious agents, including bacteria, parasitic worms and viruses, was recently estimated to be 420% (Bouvard et al., 2009) . The contribution of several viruses is especially high in certain cancer types. For instance, human hepatitis B virus (HBV) and human hepatitis C virus (HCV) are associated with 80% of hepatocellular carcinomas (HCCs), EBV is associated with 30% of Hodgkin's lymphomas and HPV is positive in 495% of cervical carcinomas (zur Hausen, 2006) . Many of the products from these oncogenic viruses (oncoviruses) carry out functions that disrupt cell processes, such as apoptosis and cell-cycle checkpoint activation (McLaughlin-Drubin and Munger, 2008) . Although oncoviruses from different virus families use diverse strategies that contribute to cancer development, they share many common features, among which the interactions with cellular targets such as p53 and Rb (Javier and Butel, 2008; McLaughlin-Drubin and Munger, 2008) are of particular note.
Known and potential human tumor viruses belong to a number of families, either DNA viruses or RNA viruses that retrotranscribe their genome to DNA. General information about these viruses with known and potential associations with human cancer is provided in Table 1 .
Oncoviruses tend to cause persistent infections because they have developed strategies for evading the host immune response. However, viruses are not sufficient for carcinogenesis, and additional factors, including host immunity and cell mutations, are necessary for a tumoral process to be initiated (McLaughlin-Drubin and Munger, 2008) .
Viruses that establish latent infections need to avoid recognition by the immune system, as this would otherwise eliminate the infection. Different viral evasion strategies have been identified, but all of them are essentially aimed at camouflaging the virus in the host cell, restricting the expression of viral genes and proteins that are indispensable for viral persistency, and avoiding the expression of genes associated with immune response. Viral DNA methylation could be the masking mechanism by which many viruses are able to achieve this (Fernandez et al., 2009) .
DNA methylation is responsible, through the silencing of repetitive genomic sequences, for the inactivation of integrated foreign DNA, that is, retrotransposons such as L1 and ALU elements, proviral sequences from endogenous retroviruses and other transposable elements. (Yoder et al., 1997; Colot and Rossignol, 1999) . In this regard, it has been proposed that DNA methylation may have arisen as a genome-defense system to prevent chromosomal instability, translocations and gene disruption caused by the reactivation of these transposable DNA sequences (Yoder et al., 1997; Rollins et al., 2006) . In addition, eukaryotic cells have developed several defense mechanisms against the uptake, integration and continued expression of foreign DNA (such as viruses) in which gene-specific sequence methylation has an important role (Doerfler, 1991) . This de novo methylation of foreign genes in eukaryotic genomes can be viewed as an ancient cell defense mechanism against the intrusion of foreign genetic material (Doerfler, 1991 (Doerfler, , 1996 . Many studies have shown that viruses can cause methylation of the host cell genome by interacting with the host epigenetic machinery, thus driving the silencing of host cellular genes. Viruses are also able to alter the activity of proteins associated with the establishment of specific histone marks, chromatin remodeling complexes and miRNA processing (Flanagan, 2007; Javier and Butel, 2008; Ferrari et al., 2009; Whitby, 2009) .
In this review, we summarize the epigenetic information available about the main viruses with known and potential associations with human cancer or that are involved in human tumorigenesis. It is widely accepted that the virus genome disrupts the host genome by insertion mutations and chromosomal rearrangements, predisposing the infected cells to cancer. It is also known that, apart from introducing genetic changes, the presence of the viral genome is associated with an aberrant methylation profile in host-specific genes in human cancer. However, little is known about the epigenetic changes in the virus itself, the study of which may help to explain the molecular mechanisms of viral pathogenesis and tumorigenesis. As in eukaryotic cells, DNA methylation is the best-studied epigenetic mark in viruses. We will also describe the specific histone modification marks within the viral genomes and the miRNA profiling associated with their pathogenicity and tumorigenicity, and the main alterations in the epigenetic machinery of the host cell associated with the activity of various viruses. Table 2 lists the viral genes and enomic regions reported to have epigenetic changes, as well as their associated function in the cell and/or various cancers.
Epstein-Barr virus
EBV was the first human tumor virus to be discovered, in the 1960s. This is a double-stranded DNA virus of the herpes family and is one of the most common viruses in humans: 90% of the world's adult population is infected by it (Table 1) . The virus persists in most individuals as a lifelong asymptomatic infection of B-lymphocytes. When the primary infection occurs during adolescence or early adulthood, it induces infectious mononucleosis in about half of the individuals (Young and Rickinson, 2004; Williams and Crawford, 2006; Klein et al., 2007) . EBV is also associated with several human malignancies, including Burkitt's lymphoma (Georg, 2009) , nasopharyngeal carcinoma, T-cell lymphoma and gastric carcinoma (Fukayama et al., 2008) . In addition, EBV infection is involved in the etiology of several lymphoid and epithelial malignancies in immune-compromised humans, such as AIDS and post-transplant patients (Niller et al., 2008) .
The EBV genome exists in two different states in the host-lytic and latent-but all phases of the EBV life cycle are associated with human diseases. The lytic cycle causes the expression of several viral proteins that finally produce infectious virions. The latent cycle does not give rise to the production of virions, but a limited number of proteins, known as 'latent proteins', are produced in this stage. These latent genes encode the EBV nuclear antigens EBNA1, 2, 3A, 3B, 3C and LP, the latent membrane proteins (LMP)1, 2A and 2B, the BARF-1 protein and the EBER 1, EBER 2 and BART RNA transcripts. In addition, EBV codes for at least 20 miRNAs that are expressed in latently infected cells (Tao et al., 1998; Klein et al., 2007; Georg, 2009 ). The epigenetic regulation of viral genes is a very important event in the life cycle of EBV (Park et al., 2007b) . The expression of latent viral oncogenes, RNAs and miRNAs, is under epigenetic control by DNA methylation and histone modifications that result in the complete silencing of the EBV genome (Niller et al., 2008) . Although the linear double-stranded EBV genomes packaged into virions are unmethylated, certain viral gene promoters of latent, circular EBV genomes may undergo increased methylation (reviewed by Niller et al. (2008) .
The stages of EBV latency (0, I, II, III) are defined with respect to the expression of specific latent genes, and at the same time are associated with a particular tumor type. Different methylation patterns in the latent genes are related to these latency states (zur Hausen, 2006) .
Methylation of the EBV genome may protect the host cell through the repression of transforming latency genes (Robertson and Ambinder, 1997) . Despite this, the virus uses DNA methylation to maximize persistence and conceal itself from immune detection, inhibiting expression of viral latency proteins that are recognized by cytotoxic T cells (Robertson and Ambinder, 1997; Paulson and Speck, 1999; Tao and Robertson, 2003; zur Hausen, 2006; Fernandez et al., 2009) .
EBV is the most comprehensively studied virus with respect to regulation of gene expression by DNA methylation. There are many studies describing the methylation profiles of specific genes, especially those associated with the type of latency state (Tao et al., 1998; Ambinder et al., 1999; Paulson and Speck, 1999; Park et al., 2007b; Fejer et al., 2008) . The methylation profiles of these promoters have been analyzed by methylation-specific PCR, bisulfite sequencing and pyrosequencing (Tao et al., 1998; Ambinder et al., 1999; Paulson and Speck, 1999; Li and Minarovits, 2003; Tao and Robertson, 2003; Park et al., 2007b; Fejer et al., 2008; Niller et al., 2008; Fernandez et al., 2009) .
The methylation profile of the promoter gene coding for the EBV nuclear antigen 1 (EBNA1) is the most extensively analyzed epigenetic mark in this virus. EBNA1 is indispensable for viral DNA replication and episome maintenance in latency. Four promoters (Cp, Wp, Qp and Fp) that drive EBNA1 expression have been described (Tao et al., 1998) , and there is evidence that DNA methylation regulates the expression of this gene and ultimately defines the type of latency stage. CpG methylation switches off gene expression and induces the alternative transcription of EBNA1 from various promoters in the different latency stages that, at the same time, are associated with the pathology that the virus induces, from a simple infection to a lymphoma or carcinoma (Li and Minarovits, 2003; Yoshioka et al., 2003; Niller et al., 2008) . Although Wp, Cp and Fp have been found methylated in a specific latency type, Qp remains unmethylated, irrespective of its activity, and is thought to be regulated by a putative repressor protein and specific histone modifications (Tao et al., 1998; Paulson and Speck, 1999; Salamon et al., 2001; Li and Minarovits, 2003; Tao and Robertson, 2003; Minarovits, 2006; Fejer et al., 2008; Fernandez et al., 2009 ).
Another gene that escapes methylation silencing codes for the LMP1, which is the main viral oncogene, and activates cell signaling pathways such as NF-kB, inducing the expression of various genes that encode antiapoptotic proteins and cytokines (Young and Rickinson, 2004) . Paradoxically, LMP1 might promote the methylation of its own encoding EBV genome by enhancing the expression of DNA methyltransferase 1 (DNMT1) (Tsai et al., 2006) . In the same manner, tumor-suppressor genes in nasopharyngeal carcinoma have been found to be hypermethylated through LMP1-induced DNMT1 activation (Niemhom et al., 2008) . Similarly, LMP2A is an intermediate in the activation of DNMT1 that causes loss of expression through promoter methylation in the tumor-suppressor gene PTEN in gastric carcinoma (Hino et al., 2009) .
Although methylation helps the virus evade the host immune system, EBV can be reactivated lytically and is able to take advantage of this epigenetic mark to initiate replication. This reactivation is initiated by the expression of the immediate-early gene BZLF1, which encodes the transcriptional activator Zta, probably by stimuli such as plasma cell differentiation, and has been found to be unmethylated (Fernandez et al., 2009 ). This protein, apart from affecting the expression of host genes (Chang et al., 2006) , has the ability to bind to methylated sites and activate the expression of BRLF1, another of this virus's immediate-early genes, and both together then activate the expression of the remaining lytic genes, thereby inducing a lytic infection (Bhende et al., 2005; Countryman et al., 2008; Dickerson et al., 2009; Heather et al., 2009 ).
An exhaustive analysis of the DNA methylation profiles of the complete set of genome promoters of EBV has been carried out recently (Fernandez et al., 2009) , in which were examined the transcription start sites of all the genes in several EBV-positive tumor samples that included various benign proliferating cells, and primary tissues and cell lines from EBV-associated lymphomas and nasopharyngeal carcinomas. It was shown that out of all the samples, five gene promoters did not possess the DNA methylation mark: the two structural RNAs, EBER1 and EBER2, and Qp, BZLF1 and LMP2B/LMP1. The methylation patterns in the rest of the gene promoters changed depending on the type of sample (Figure 1 ). In this study, the authors found occasional hypermethylation in nontumorigenic human B-cell-derived lymphoblastoid cell lines, although this pattern was significantly different in cancer cells, as the majority of lymphoma and nasopharyngeal samples from primary tumors and cell lines had a large number of hypermethylated transcription start sites (Figures 1 and 2 ). In addition, they confirmed the close association between a methylated transcription start site and its loss of transcription at the single gene level using different functional approaches (Fernandez et al., 2009) (Figure 2 ).
Histone marks are other epigenetic marks that have been investigated in this virus in recent years. During latency, episomal DNA is associated with nucleosomes in arrays that are indistinguishable from bulk cellular DNA (Shaw et al., 1979; Dyson and Farrell, 1985) and, not surprisingly, the histone marks associated with particular nucleosome positioning affect the expression patterns of viral genes. Several studies have been published in relation to this that identify specific associations between the expression of viral genes and patterns of histone modification (Gerle et al., 2007; Countryman et al., 2008; Fejer et al., 2008) .
Histone H3 lysine 4 dimethylation (H3K4Me2) has been associated with gene expression in several species, including humans. This and histone H3 lysine 4 trimethylation (H3K4me3) are enriched at actively transcribed genes (Bernstein et al., 2005; Wiencke et al., 2007) . Similarly, the relationships between histone acetylation and gene transcriptional activation by rendering chromatin accessible to the transcriptional machinery are widely recognized (Bernstein et al., 2007; Esteller, 2008) . Recently, studies of these histone marks in specific promoter regions in the EBV genome have yielded some interesting results from an analysis of the epigenetic patterns of viral genes, such as Cp, LMP2A and BZLF1, which code for essential latent proteins. As these histone marks are associated with open and accessible chromatin, these results suggested that, in coordination with DNA methylation, they have a major role in the modulation (activation or repression) of specific viral genes (Gerle et al., 2007; Countryman et al., 2008; Fejer et al., 2008) .
Finally, it is important to note that EBV was the first virus reported to express miRNAs (Pfeffer et al., 2004) . All of the herpesviruses analyzed until now express miRNAs and, in particular, EBV is known to encode 420 miRNAs (Cai et al., 2006; Grundhoff et al., 2006; Gurtsevitch, 2008; Cullen, 2009 ) that are differentially expressed in the different phases of the viral life cycle and between types of latency (Cai et al., 2006) . EBVencoded miRNAs regulate both host and viral genes, hence an investigation of these relationships is very important for our understanding of the biological processes involved in viral latency, which could be exploited to design strategies for combating potential harm to the host (Pfeffer et al., 2004; Nair and Zavolan, 2006; Scaria et al., 2006; Gottwein and Cullen, 2008) . In this regard, the interactions between BART miRNAs, such as miR-BART16, and LMP1, the most oncogenic known gene in EBV (Table 1) , have been demonstrated (Grey et al., 2008; Cullen, 2009 
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Furthermore, DNA methylation associated with loss of expression in Akata Burkitt's lymphoma cells was found in the miR-BHRF1-1 located in the 5 0 -untranslated region of the BamH1 fragment H rightward open reading frame 1 gene (BHFR1), which is one of the two main miRNA clusters in EBV (Pfeffer et al., 2004; Cai et al., 2006; Fernandez et al., 2009) (Figure 2 ). These results suggest that, in addition to its role in controlling the expression of protein-coding genes involved in viral latency, DNA methylation also mediates the regulation of miRNA expression.
Kaposi's sarcoma-associated herpesvirus KSHV, also known as human herpesvirus 8 (HHV-8), is the second herpesvirus to be associated with human cancer. It was discovered in 1994 by Chang and Moore and colleagues and is associated with Kaposi's sarcoma (one of the commonest cancers in human immune deficiency virus (HIV)-infected individuals), primary effusion lymphoma and some types of multicentric Castleman's disease (zur Hausen, 2006) .
It is a double-stranded DNA virus and, similar to EBV, its infection persists for life (Table 1) . The virus can establish two different expression programs. In latency, the expression of viral genes is kept to the minimum to maintain the episome and to enable it to persist through cell replication cycles. In the lytic state, the virus reactivates the production of entire virions and lyses the newly infected host cells (Jenner et al., 2001; Dourmishev et al., 2003; zur Hausen, 2006; Horenstein et al., 2008) .
There are seven KSHV genes closely associated with latency and that are potentially tumorigenic: LANA, vcyclinD, vFLIP (K13), Kaposin (K12), vIRF2 (K11.5), vIRF3 (K10.5) and LAMP (K15). All of them are linked to viral maintenance and to the perturbation of the host immune response (Dourmishev et al., 2003; zur Hausen, 2006; Areste´and Blackbourn, 2009 ). In particular, several of these proteins (LANA, v-cyclinD, vFLIP and kaposin) can affect the main tumorigenic pathways involved in regulating important tumor suppressors and oncogenic genes in mammals (Godden-Kent et al., 1997; Friborg et al., 1999; Radkov et al., 2000; Fujimuro et al., 2003; Guasparri et al., 2004; McCormick and Ganem, 2005; Bubman et al., 2007; Di Bartolo et al., 2008) .
Overall, the latency-associated nuclear protein (LANA) (Kedes et al., 1997) is the main and most studied protein in KSHV. LANA participates in the maintenance of the episome during latency. It also links the episome to the host cell chromosome and binds to the viral repeat elements (TR) of the viral genome to mediate its replication (Ballestas et al., 1999; Cotter and Robertson, 1999; Verma et al., 2007) . The interactions between LANA and cellular and viral proteins, such as those encoded by p53, pRB or replication and transcription activator (Rta), among others, are summarized by zur Hausen (2006) , who also reviews its regulatory role in the expression of genes involved in the main cellular pathways.
The epigenetic regulation of KSHV replication and the epigenetic changes induced by the virus in the host genome have also been described (see reviews by Ferrari et al. (2009); Pantry and Medveczky (2009) ).
The KSHV DNA epigenome has only been partially analyzed (Table 1) , but the epigenetic mediation of the establishment and maintenance of the latency of this virus has been demonstrated. LANA is unmethylated (Chen et al., 2001) and is known to be associated with histone modifications and subsequent gene expression alterations in host and viral genes that contribute to viral oncogenesis (Sakakibara et al., 2004; Lu et al., 2006; Stuber et al., 2007) . It has also been shown that the recruitment of a de novo methyltransferase (DNMT3b) causes downregulation of genes such as cadherin 13 and TGF-b by promoter methylation (Shamay et al., 2006; Di Bartolo et al., 2008) .
The Rta encoded by ORF50 is another feature that is as well studied as LANA in this virus (Sun et al., 1998) . During latency, ORF50 is repressed and the direct or indirect effects of LANA and/or DNA methylation of this gene promoter participate in the regulation of its expression (Chen et al., 2001; Lu et al., 2006; Li et al., 2008; Gray et al., 2009) .
Finally, miRNAs encoded by KSHV are involved in epigenetic regulation and expression of oncogenes (Cai et al., 2006; Flanagan, 2007; Samols et al., 2007) , hence their study should help us to better understand the molecular mechanisms of viral tumorigenesis.
Human papilloma virus
HPVs are currently believed to be the most common cause of cancers induced by an infectious agent (zur Hausen, 2006 (zur Hausen, , 2009 Whiteside et al., 2008) . HPVs are a group of viruses of the Papillomaviridae family, which contain double-stranded circular DNA of B8 kb (Table 1) and use the host DNA machinery to replicate and proliferate. In general, the genome is divided into three regions: an upstream regulatory region or long control region (LCR); the early region, composed of six open reading frames (ORFs) known as E1, E2, E4, E5, E6 and E7; and the 'late region', with two ORFs coding for viral structural proteins L1 and L2 (Zheng and Baker, 2006) . This virus infects the squamous epithelia of many species, and in humans, 4100 papillomavirus genotypes have been identified, which differ in sequence among themselves by at least 10% within the most conserved region (L1) (de Villiers et al., 2004; zur Hausen, 2006) .
In the 1970s, a relationship was first established between papillomavirus infections and cervical cancer (zur Hausen, 1977) . Many studies have since been conducted and today it is well known that HPVs cause most cancers of this type and also a proportion of anogenital, head and neck and other cancers (zur Hausen, 2009) .
Although HPVs are responsible for a variety of benign proliferations, infection with two of the high-risk mucosal HPVs, such as HPV16 and HPV18, causes squamous intraepithelial lesions that can progress to invasive squamous cell carcinoma. For example, they are present in 495% of cervical and 470% of anal cancers (zur Hausen, 2006) . E2, E6 and E7 are the most widely studied viral genes because of their relationships with oncogenic processes. Whereas E2 is involved in viral DNA replication and the regulation of early transcription, E6 and E7 are genuine viral oncogenes, the expression of which induces cell immortalization and transformation.
During carcinogenic progression, the HPV genome often integrates into the host cell chromosome. In this way, the virus is not only able to complete its life cycle but can persist in the host cell and initiate oncogenesis. This integration frequently disrupts the E1-E2 genome region, resulting in a loss of expression of the E2 viral gene, which is a transcriptional repressor of E6 and E7 gene expression, and leads to an increase in expression of both oncoproteins.
E6 and E7 inactivate p53 and pRb, two classical tumor-suppressor genes (Zheng and Baker, 2006) , and also interact with other cell proteins, thereby affecting the integrity of key pathways. Several recent studies have shown that E6 and E7 bind to different cell proteins involved in the processes of adhesion, apoptosis, cell cycle, DNA repair, metabolism, signal transduction, transcription and other functions (Horikawa and Barrett, 2003; Whiteside et al., 2008; Howie et al., 2009; McLaughlin-Drubin and Mu¨nger, 2009 ). In addition, deregulation of the expression of several miRNAs in the host cells associated with HPV infection induced by some of its oncoproteins has been noted by several authors (Martinez et al., 2008; Reshmi and Pillai, 2008; Wang et al., 2008 Wang et al., , 2009 .
Apart from introducing genetic changes, neoplastic processes induced by HPV infection have also been linked to viral and host epigenetic changes, including DNA methylation and histone modifications, which contribute to pathogenesis and tumorigenesis. In fact, DNA methylation in host cell genes has been investigated as a potential biomarker for early detection of cervical cancer by extensive screening of premalignant and invasive cervical carcinoma samples (Lai et al., 2008; Whiteside et al., 2008; Fernandez et al., 2009; Ferrari et al., 2009; Wentzensen et al., 2009) .
DNA methylation in HPV was first described nearly 30 years ago (Danos et al., 1980) and its role in carcinogenesis has been studied subsequently. HPV16 and HPV18 are the most thoroughly analyzed virus types, as they represent the high-risk types of HPV. These DNA methylation profiles have been analyzed at the gene and global genome levels in several studies. The de novo methylation of HPV DNA has been interpreted as being a host defense mechanism for silencing viral replication and transcription that is exploited by the virus to maintain a long-latency infection (Doerfler, 1991; Kalantari et al., 2004; Woodman et al., 2007; Fernandez et al., 2009) . These dynamic changes in viral DNA methylation profiles during tumorigenesis were highlighted in a study of cultured primary human foreskin keratinocytes transfected with the entire genome of HPV16 or HPV18, which results in its integration into the host cell genome (Steenbergen et al., 1996) . The HPV16 and HPV18 'DNA methylomes' from preimmortal keratinocytes were found to be almost completely unmethylated, whereas the immortal descendant cells featured densely methylated viral genomes (Fernandez et al., 2009) . As the HPV genome does not code for any known gene involved in the DNA methylation machinery, it is believed that the viral genome is methylated by human host cell DNA methyltransferases (DNMTs).
Previous studies of HPV16 DNA methylation have analyzed the entire LCR and L1 regions (Badal et al., 2003 (Badal et al., , 2004 Kim et al., 2003; Kalantari et al., 2004; Bhattacharjee and Sengupta, 2006; Turan et al., 2007; Hublarova et al., 2009) . Even more recent studies have been able to map the DNA methylation of every CpG (DNA methylome) in a collection of human cervical samples corresponding to the different progressive stages of the disease, from asymptomatic carriers to primary cervical carcinomas and several established cervical cancer cell lines (Brandsma et al., 2009; Fernandez et al., 2009) .
Viral DNA hypermethylation has been observed to be more closely associated with carcinomas than with asymptomatic infections or dysplasias (Figure 1) . In HPV16 and HPV18 types, the LCR and E6 sequences were commonly found to be unmethylated independent of the stage of neoplastic progression, although the L1 region was densely methylated (Badal et al., 2003 (Badal et al., , 2004 Turan et al., 2006 Turan et al., , 2007 Hublarova et al., 2009) .
Methylation patterns similar to those observed in previous studies were recently described in global DNA methylomes of these viruses, although there were some peculiarities. In the case of HPV16, LCR was observed to be methylated in some primary cervical carcinomas, especially at E2-binding sites (E2BS, located within LCR) (Bhattacharjee and Sengupta, 2006; Brandsma et al., 2009; Fernandez et al., 2009) . It has been shown in vitro that DNA methylation of the E2BS sequence inhibits the binding of E2 (Thain et al., 1996) , and that this methylation is related to the reactivation of E6 and E7 viral proteins (Fernandez et al., 2009) (Figure 3) . In this manner, in addition to gene disruption at the E2 locus, the methylation of specific LCR sequences seems to be another mechanism that induces overexpression of the oncogenic proteins E6 and E7 in advanced stages of carcinogenesis induced by HPV16 (Figure 3 ). This is especially interesting because the use of DNA demethylating agents can induce recruitment of E2 to its upstream regulatory region-binding sites and reduce E6 and E7 expression (Fernandez et al., 2009) .
In the case of HPV18, although Fernandez and collaborators found no methylation of the LCR of the classical cell lines (C4I and HeLa), they did find dense methylation in the LCR sequences of several primary cell carcinomas and also in immortal descendant cells from primary human foreskin keratinocytes transfected with the entire HPV18 genome (Fernandez et al., 2009) . They also found differential methylation of L1 in carcinomas, premalignant lesions and asymptomatic carriers, supporting the results of Turan et al. (2007) , who proposed L1 methylation as a biomarker in neoplastic progression.
Apart from methylation changes in this virus genome, other epigenetic changes might occur through direct interactions between HPV proteins (E2, E7) and cell proteins involved in DNA methylation (DNMT1) (Burgers et al., 2006) , or through processes related to the chromatin remodeling machinery (CBP, pCAF, p300, Mi2b) (Brehm et al., 1999; Patel et al., 1999; Lee et al., 2000; Peng et al., 2000; Avvakumov et al., 2003; Bernat et al., 2003) , eventually modifying the normal epigenetic processes in the host.
Hepatitis B virus
HBV is a species of the family Hepadnaviridae ( Table 1) that occurs throughout the world and is characterized by acute and chronic infections of the liver, resulting in hepatitis B, cirrhosis and HCC (Seeger and Mason, 2000; zur Hausen, 2006) . According to data provided by the World Health Organization, about 2 billion people worldwide have been infected with the virus and about 350 million live with chronic infection.
This virus contains a partially double-stranded circular DNA genome of 3.2 kb, and is one of only a few known nonretroviral viruses that replicate by reverse transcription from an RNA intermediate (pregenomic RNA), which is transcribed from covalently closed circular HBV DNA. The high mutation rate of HBV compared with that of other viruses seems to be a consequence of this reverse transcription step, which is not observed during the replication of other DNA viruses (Seeger and Mason, 2000; Yokosuka and Arai, 2006) . HBV codes for several proteins from four known genes (P, S, X and C). The P gene codes for DNA polymerase; the S gene for three polypeptides (HBs) of different sizes (large, medium and small); X for an HBx protein that is thought to be involved in hepatocarcinogenesis; and C for the core protein (Seeger and Mason, 2000; zur Hausen, 2006; Beck and Nassal, 2007; Lupberger and Hildt, 2007) .
Along with HCV (Table 1) , HBV is the main cause of the development of HCC in humans worldwide (Cougot et al., 2005; Gurtsevitch, 2008) . Although these viruses have similar names, they are genetically and clinically different. Unlike hepatitis B virus infection, persistent HCV infection is not associated with integration into the host genome because there are no DNA intermediates in the viral life cycle (Sharara et al., 1996) . In this regard, the HCV genome is not controlled by epigenetic factors such as DNA methylation or histone modifications. Nonetheless, this virus has been found to be associated with aberrant host gene promoter methylation in HCC (Tischoff and Tannapfe, 2008) .
In the case of HBV, chronic inflammation and accumulation of genetic alterations in infected hepatocytes induced by the host (Cougot et al., 2005; Gurtsevitch, 2008) and epigenetic alterations produced by viral proteins (Tischoff and Tannapfe, 2008; Herceg and Paliwal, 2009; Shon et al., 2009; Zheng et al., 2009) are mainly responsible for the carcinogenesis induced by HBV.
HBx protein and various HBs envelope proteins seem to be responsible for the alteration of major signaling pathways, including the NF-kB and Wnt/b-catenin pathways, which deregulate normal cell processes (Lupberger and Hildt, 2007; Gurtsevitch, 2008) . HBV infection is also thought to generate genomic instability through viral DNA integration or through the activity of viral proteins, producing loss and gain of chromosomal DNA, allelic losses (loss of heterozygosity, LOH), transpositions and mutations of key genes such as p53, RB or hTERT (Horikawa and Barrett, 2003; Cougot et al., 2005; Lupberger and Hildt, 2007; Gurtsevitch, 2008) .
It has also been proposed that HBV infection induces epigenetic alterations in host cells (Cougot et al., 2007; Jung et al., 2007; Park et al., 2007a; Herceg and Paliwal, 2009; Shon et al., 2009; Zheng et al., 2009 ). In such a context, HBx is a key factor initiating epigenetic alterations induced by this virus. HBx interacts with DNMTs to produce alterations in the expression of key genes through methylation of their promoters (Jung et al., 2007; Park et al., 2007a; Zheng et al., 2009) . DNMT1 expression can be activated by HBx and this increase can then inhibit the expression of tumorsuppressor genes such as p16 or E-cadherin (Jung et al., 2007) . HBx can also regulate the expression of DNMT3a and DNMT3b or interact directly with them, resulting in the hypermethylation or hypomethylation of the promoter regions modulating gene expression (Park et al., 2007a; Zheng et al., 2009) . In addition, interactions are known to occur between HBx and the chromatin remodeling machinery components (Cougot Interactions between HBx and histone acetyltransferase (HAT) CBP/p300 are associated with the modulation of gene expression (Cougot et al., 2007) , and those with histone deacetylase 1 (HDAC1) have been associated with gene repression (Shon et al., 2009; Zheng et al., 2009) . In a recent review, Zdenko Herceg and Anupam Paliwal proposed three hypothetical models that combined the interactions between HBx and the various epigenetic factors to explain the gene expression modulation induced by the virus (Herceg and Paliwal, 2009 ). HBV replication is also associated with specific epigenetic marks such as the acetylation of H3 and H4 (Pollicino et al., 2006) . At the same time, it seems that the expression of viral genes is regulated by DNA methylation. All studies, from the first in 1983 (Miller and Robinson, 1983) to those of the present day, have revealed DNA methylation in the HBV genome. In addition, DNA methylation of several viral genes is known to be associated with loss of their expression (Vivekanandan et al., 2008 (Vivekanandan et al., , 2009 Fernandez et al., 2009; Guo et al., 2009 ). Nevertheless, very few studies have attempted to analyze the viral methylation of specific sequences. Recently, Fernandez and collaborators completed their description of HBV 'DNA methylomes' from different stages of liver tumorigenesis, from chronic active hepatitis and hepatic cirrhosis to primary hepatocarcinomas and a well-characterized panel of hepatic cancer cell lines (Fernandez et al., 2009) . Bisulfite sequencing analysis showed that, in all the liver cancer cell lines studied, most of the HBV genomes, although more methylated than in the premalignant lesions, retained the X gene coding for HBx in an unmethylated state, consistent with it being actively transcribed. However, the presence of DNA methylation at the S and C genes was associated with their lack of expression (Fernandez et al., 2009) . HBx is probably involved in the establishment of DNA methylation patterns within the HBV genome in the same way as has been described for host genes (Jung et al., 2007; Park et al., 2007a; Zheng et al., 2009) .
These results, obtained by bisulfite sequencing and methylation-specific PCR, are in concordance with those from HPV and EBV obtained by the same authors, who saw an increase of viral DNA methylation from early to late stages of carcinogenesis progression (Figure 1) .
Finally, although HBV could be involved in the deregulation of some of the host miRNAs (Liu et al., 2009) , only one miRNA encoded by HBV was found, which seems be involved in regulating its own gene expression (Jin et al., 2007) .
Human T-cell leukemia virus type 1
Human T-cell leukemia virus type 1 (HTLV-1) is a single-stranded RNA retrovirus that infects 20 million people worldwide (Proietti et al., 2005) (Table 1) . It was discovered in 1980 (Poiesz et al., 1980) , and was associated with adult T-cell leukemia (ATL) shortly thereafter (Hinuma et al., 1981) . At present, HTLV-1 is the only human retrovirus known to be directly associated with a human neoplasia.
Although it is not clear whether HTLV-1 is integrated randomly into the host genome (Doi et al., 2005; Derse et al., 2007) , it is thought that this virus does not cause cancer by insertional mutagenesis or by capturing and activating cellular proto-oncogenes (Matsuoka and Jeang, 2007) . It is accepted that Tax is the main transforming protein of HTLV-1. Tax modulates the expression of viral genes through the viral long terminal repeats (LTRs) and also alters the NF-kB and Akt survival pathways promoting cell survival and proliferation, creates chromosomal instability and silences p53, among other activities (Matsuoka and Jeang, 2007; Yasunaga and Matsuoka, 2007; McLaughlin-Drubin and Munger, 2008) .
Although Tax is required for transformation, only around 40% of the ATLs are Tax positive. Recent studies have shown that the basic leucine zipper factor (HBZ), encoded by the negative strand of the provirus, is responsible for viral maintenance during ATL transformation. In this regard, it seems that Tax is necessary for initiating transformation, whereasHBZ maintains it (Matsuoka and Jeang, 2007) . As in the case of the viruses already described in this review, this repression of a viral protein (Tax) could be associated with the evasion of the immune response, as Tax is the main target of the host's cytotoxic T-lymphocyte response (Takeda et al., 2004) .
There are several mechanisms by which Tax expression could be lost in ATL cells. Besides deletions of 5 0 -LTR or mutations in the Tax gene, 5 0 -LTR DNA methylation of the provirus occurs in 15% of cases (Koiwa et al., 2002; Takeda et al., 2004; Taniguchi et al., 2005; Matsuoka and Jeang, 2007) . Tax can also modulate its own expression by recruiting a histone methyltransferase (SUV39h1) to the 5 0 -LTR and inducing repressive histone modification on the chromatin through H3 K9 methylation (Kamoi et al., 2006) .
Several studies have found DNA hypermethylation of the 5 0 -LTR in latency stages of ATL development that was associated with a lack of viral gene expression (Koiwa et al., 2002; Takeda et al., 2004; Taniguchi et al., 2005) . Taniguchi and co-workers have demonstrated this in a more comprehensive study and have additionally shown that methylation occurs in internal provirus sequences . They also found that 5 0 -LTR was more highly methylated in ATL cells than in carriers, among cases with methylated 5 0 -LTR, which is consistent with the previously proposed model in which virus DNA methylation increases from early to late stages of tumorigenesis progression (Fernandez et al., 2009) .
Furthermore, the 3 0 -LTR, from which HBZ is transcribed, has been found intact and unmethylated in all stages of ATL development in all previous studies (Koiwa et al., 2002; Takeda et al., 2004; Taniguchi et al., 2005) , which is further evidence of this gene's importance in ATL maintenance. In addition to its role in ATL proliferation, HBZ has been associated with downregulation of viral transcription mediated by Tax through the 5 0 -LTR (McLaughlin-Drubin and Munger, 2008) . These results highlight the importance of carrying out a deep analysis of viral genomes and the epigenetic features that modulate the viral life cycle, especially when the virus is related to human cancer.
Other viruses associated with human cancer Besides those described above, there are other viruses with a potential influence on human carcinogenesis. Recent studies have produced evidence of the infectious etiology of numerous cancers, and in this respect, the direct or indirect action of several viruses has been examined at both genetic and epigenetic levels. Below, we summarize the main findings with regard to epigenetic alterations in these potential oncoviruses.
Human immune deficiency viruses
HIV types 1 and 2 are the classical indirect carcinogens. Immunosuppression induced by these infections results in a higher frequency of tumors caused by other oncogenic viruses such as EBV, HPV and KSHV (zur Hausen, 2006; Elgui de Oliveira, 2007) . These viruses belong to the Retroviridae family (Table 1) and, similar to HTLV-1, after infection, the viral RNA genome is converted into double-stranded DNA by a virally encoded reverse transcriptase. This viral DNA is then integrated into cellular DNA by a virally encoded 'integrase', and the virus can become latent, allowing infected cells to maintain their normal functions, or the virus can become active, lysing the host cell after its replication and subsequently infecting other cells.
Although there are no data to confirm the direct role of HIV in human tumorigenesis, infected patients are known to be at higher risk of developing cancers. It seems that the immune deficiency induced by HIV is responsible for tumorigenesis through the action of oncoviruses such as EBV, KSHV and HPV, which cause lymphomas, Kaposi's sarcomas and cervical carcinomas (International Collaboration on HIV and Cancer, 2000; Kinlen, 2004; Carbone and Gloghini, 2005; Carbone et al., 2007 Carbone et al., , 2009 Grulich et al., 2007) .
HIV primarily infects vital cells in the human immune system, such as helper T cells, macrophages and dendritic cells, but the main reservoir in virus latency is the CD4 þ memory T cells. Several studies support the idea that the latent state of integrated provirus is stabilized by the establishment of some suppressive epigenetic marks, such as DNA methylation or a specific histone code, particularly at the viral promoter (Bednarik et al., 1990; Ishida et al., 2006; Jiang et al., 2007; Mok and Lever, 2007) . Latency with persistence of the entire virus, especially in the case of HIV, is very important because it provides a reservoir of viruses that are potentially harmful and able to trigger a carcinogenic process. Indeed, long-term HIV infection increases the risk of cancers associated with other virus infections (Grulich et al., 2007) .
The proviral control of gene expression and its own silencing has been a major objective of study in recent years because of the importance of understanding the molecular mechanisms that control it. Several models have been proposed to explain proviral silencing (Mok and Lever, 2007; Han et al., 2008; Duverger et al., 2009; Richman et al., 2009) . Although DNA methylation of the HIV 5 0 -LTR is known to suppress viral gene expression (Bednarik et al., 1990) , more complex processes have been discovered that govern this transcriptional feature.
The influence of DNA methylation on proviral gene expression is controversial and usually depends on the host genome environment in which the virus is integrated Duverger et al., 2009) . Thus, Mok and collaborators have proposed a model in which proviral integration and silencing could be established at different times and by different mechanisms depending on the location in the host genome (Mok and Lever, 2007) . If the virus is integrated in a region that is nonpermissive for gene expression, which is probably correlated with DNA methylation, the provirus is promptly silenced, but if it is integrated into a permissive chromatin region, viral genes may be expressed and proviral silencing could therefore be delayed. The importance of the role of chromatin remodeling factors, including histone deacetylases (HDACs) and HATs, in proviral gene expression has been widely noted (Jiang et al., 2007; Mok and Lever, 2007) .
Recent studies have shed more light on these complex silencing mechanisms (Duverger et al., 2009; Richman et al., 2009) . A new mechanism regulating viral gene expression has emerged, explaining the lack of associations between the gene silencing and histone modifications or DNA methylation found in many cases. This is the so-called 'transcriptional interference' by which the constant presence of the host transcriptional machinery in the active region in which the virus is integrated interferes with transcription initiation from the viral promoter (Duverger et al., 2009; Han et al., 2008; Lenasi et al., 2008) .
Finally, the role of endogenous miRNAs that may impede provirus transcription or translation (Richman et al., 2009 ) is worth noting, although more research is needed to determine the complex genetic and epigenetic mechanisms by which this virus may finally induce cancer.
Human cytomegalovirus and HHV-5
Human cytomegalovirus (HCMV) is the largest herpesvirus (4230 kb) (Table 1) and it infects 50-100% of adults worldwide (Michaelis et al., 2009) . Similar to all members of this family, it can remain latent within host cells for long periods. Although initial HCMV infection is asymptomatic, some people may develop an infectious mononucleosis or a mild hepatitis. However, the mechanism by which HCMV may contribute to tumorigenesis remains unclear.
Although HCMV is not considered to be oncogenic, its infection has been implicated in carcinogenesis by different pathways, and the concept of 'oncomodulation' emerged to explain the role of this virus in tumor progression (Cinatl et al., 1996 (Cinatl et al., , 2004 Michaelis et al., 2009) .
DNA methylation in HCMV gene promoters has been associated with in vitro and in vivo silencing, although only in animal models, in which it is thought to contribute to the modulation of viral latency (Prosch et al., 1996; Brooks et al., 2004) .
Nevertheless, several studies in animal and human models have identified associations between chromatin remodeling factors and specific histone marks associated with viral gene expression. It is suggested that viral proteins target HDACs and may modulate viral and cellular gene expression (Reeves et al., 2006; SoderbergNaucier, 2006; Park et al., 2007c; Mehta et al., 2009) .
Changes in histone acetylation and methylation patterns in HCMV have been found in different stages of infection (Cuevas-Bennett and Shenk, 2008) . Other studies show that in lytically infected cells, the HCMV enhancer is associated with histone H3 lysine 9 (H3K9) hyperacetylation but not H3K9 dimethylation. By contrast, in latent infection, the HCMV enhancer was not associated with either acetylation or dimethylation of H3K9 (Ioudinkova et al., 2006) .
In addition, several miRNAs encoded by HCMV have recently been discovered and, in some cases, associated with changes in gene expression that ultimately affect viral replication (Dolken et al., 2009) .
Taken together, all these findings highlight once again the importance of epigenetic factors in the modulation of viral gene expression and their association with the induction of or contribution to carcinogenesis.
Polyomaviruses: SV40, JCV, BKV and MCV
Polyomaviruses are small double-stranded DNA viruses from the Polyomaviridae family (Table 1) . Although polyomaviruses are potent tumor viruses under experimental conditions, the association with human malignancies remains controversial. The high tumorigenicity in cell culture and animal model systems reveals them to be genuine oncogenic agents.
These viruses are involved in several human diseases (Jiang et al., 2009 ), but no conclusive evidence exists that they cause or act as a cofactor in human cancer. However, a wide range of reports have indicated the presence of viral genomic sequences in multiple human cancers such as osteosarcomas, mesotheliomas, brain tumors, gliomas, medulloblastomas, colorectal carcinomas and skin cancers (Table 1) (Goel et al., 2006; McCabe et al., 2006; Feng et al., 2008; Jiang et al., 2009) .
Human polyomaviral genomes need the host machinery for replication, and two viral proteins (T antigens) are involved in ensuring that this requirement is met (Damania, 2007; Levine, 2009 ). These T antigens seem to be involved in inactivating tumor-suppressor genes such as Rb or p53, causing cell proliferation and initiation of oncogenic transformation (Levine, 2009) .
Little conclusive data exist about viral epigenetic profiles and the role of epigenetic factors in viral gene expression and latency, but recent studies have found evidence that viral miRNAs expressed late during infection might regulate viral early gene expression (Seo et al., 2008) .
However, polyomaviruses have been found to induce epigenetic alterations within the host cell. T antigens are largely responsible for these alterations, and may interact with HATs (p300 and CBP) to enhance or repress gene expression (DeCaprio, 2009), or may induce aberrant methylation, possibly mediated by DNMTs (McCabe et al., 2006) , in host gene promoters in several tumor types (Li et al., 2005; Goel et al., 2006) .
It would be interesting to know how epigenetic modulation allows these viruses to persist as latent infections. Further studies of DNA methylation and histone modifications in the viral genome will enable us to elucidate the various mechanisms involved in tumorigenesis.
Conclusions and perspectives
Once the viral etiology of the different human cancer types has been established, preventive approaches would be the first step toward neutralizing the establishment of a viral infection, for which reason designing new vaccines against potential oncoviruses will be of greatest interest. This is already the case for the papilloma viruses and hepatitis B virus, but not for others such as EBV, KSHV and human polyomaviruses, which are associated in some cases with very aggressive cancer types.
However, when the infection is established, the molecular mechanisms by which some viruses induce or are associated with carcinogenic processes are not very clear. At this point, it becomes very interesting to study the molecular mechanisms and the genetic and epigenetic factors that determine where and why a virus is capable of initiating a tumoral process.
Overall, oncogenic viruses seem to attack the same cellular control pathways, although by different routes, affecting cell cycle, apoptosis, senescence, DNA repair or changes in metabolism, in which p53 and pRb, two classical tumor-suppressor genes, have an important role (McLaughlin-Drubin and Munger, 2008) . In fact, most of the therapies for cancers with an infectious etiology have been developed to target cell proteins rather than viral proteins.
Advances in research at the genetic and epigenetic levels will allow us to establish a customized implementation of more effective chemotherapy. An advantage of epigenetic over genetic changes is that the former can be reverted by use of therapeutic drugs such as DNA demethylating compounds or HDAC inhibitors. In fact, two demethylating agents, 5-azacytidine (Vidaza) and 5-aza-2 0 -deoxycytidine (Decitabine), have been approved as treatments for myelodysplastic syndrome and leukemia, and one HDAC inhibitor, suberoylanilide hydroxamic acid (Vorinostat), has been approved for the treatment of cutaneous T-cell lymphoma (Esteller, 2008) .
Epigenetic factors are strongly associated with both viral and host genome alterations during infections and with the development of tumoral processes. DNA methylation is one of the strategies that some viruses use to avoid detection by the immune system (Butel, 2000; Verma et al., 2007) ; specifically, the deregulation of DNMT family members has been proposed as one of the mechanisms that modulate gene expression in these interactions (Li et al., 2005) . Therapy with demethylating agents in this kind of pathology has not yet been used against solid tumors in vivo, but for example, DNMT3B inhibitors could potentially be useful in HCC (Park et al., 2007a) . As the DNA methylation of viral gene promoters has a major role in some virus silencing (Ambinder et al., 1999) , epigenetic therapies will be useful for exposing viral antigens to the host immune system.
In addition to DNA methylation, the role of histone marks and chromatin remodeling factors in viral and host genome alterations has prompted the in vitro investigation of the effects of epigenetic drugs that target histone modification proteins, such as HDACs (Jiang et al., 2007; Lin et al., 2009) . Furthermore, it has been proposed that the combination of epigenetic and conventional antiviral therapies, for example, unmasks HIV reservoirs and prevents the spread of the virus to uninfected CD4 þ T cells (Richman et al., 2009) .
These epigenetic drugs have nonspecific effects, hence determining the molecular mechanisms as exactly as possible and obtaining the best information about virus-host interactions are essential for developing epigenetic-specific therapies. In this context, for instance, transverse studies throughout the carcinogenic stages and the search for viral and cellular biomarkers are very important (Turan et al., 2006; Fernandez et al., 2009) . Results from such studies, aided by highthroughput technologies, will enable us to adapt customized therapies against virus-associated cancer types.
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